Vimarsana
Biggest News Aggregation in the World

Page 14 - Technology Analytics Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technology Analytics Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technology Analytics Solutions Today - Breaking & Trending Today

IQVIA (NYSE:IQV) Lifted to "Buy" at StockNews.com - Vimarsana News

IQVIA (NYSE:IQV) Lifted to "Buy" at StockNews.com

StockNews.com upgraded shares of IQVIA (NYSE:IQV – Free Report) from a hold rating to a buy rating in a research report report published on Friday morning. IQV has been the topic of several other reports. Truist Financial upped their price target on shares of IQVIA from $240.00 to $286.00 and gave the company a buy […]

Source: wkrb13.com
Balentine LLC Has $311,000 Holdings in IQVIA Holdings Inc. (NYSE:IQV) - Vimarsana News

Balentine LLC Has $311,000 Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Balentine LLC increased its position in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 23.4% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,583 shares of the medical research company’s stock after buying an additional 300 shares during the period. Balentine LLC’s […]

Source: wkrb13.com
Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight - Vimarsana News

Decoding IQVIA Holdings Inc (IQV): A Strategic SWOT Insight

Insightful Analysis of IQVIA's Position in the Evolving Healthcare Landscape

Source: yahoo.com
IQVIA (NYSE:IQV) Raised to "Buy" at StockNews.com - Vimarsana News

IQVIA (NYSE:IQV) Raised to "Buy" at StockNews.com

IQVIA (NYSE:IQV – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Friday. Several other analysts have also commented on the stock. Evercore ISI raised their price objective on shares of IQVIA from $255.00 to $265.00 and gave the stock a “market […]

IQVIA (NYSE:IQV) Given New $265.00 Price Target at Barclays - Vimarsana News

IQVIA (NYSE:IQV) Given New $265.00 Price Target at Barclays

IQVIA (NYSE:IQV – Get Free Report) had its price objective upped by analysts at Barclays from $260.00 to $265.00 in a research report issued on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the medical research company’s stock. Barclays‘s price objective would suggest a potential upside of 8.83% from the stock’s current […]